$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000111748015000018 Filed on August 06, 2015

Income Statement

Concept	2015 Q3	2015 Q2	2014 Q2
Revenue	$2.271M	$4.143M	$919.0K
YoY Change	91.65%	350.82%	13.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.613M	$7.332M	$4.423M
YoY Change	82.59%	65.77%	101.96%
% of Gross Profit
Research & Development	$26.50M	$21.86M	$8.092M
YoY Change	98.79%	170.14%	28.85%
% of Gross Profit
Depreciation & Amortization	$180.0K	$150.0K	$50.00K
YoY Change	125.0%	200.0%	-28.57%
% of Gross Profit
Operating Expenses	$35.02M	$29.09M	$12.52M
YoY Change	94.06%	132.47%	47.93%
Operating Profit	-$32.75M	-$24.95M	-$11.60M
YoY Change	94.23%	115.17%	51.46%
Interest Expense	$300.0K	$140.0K	-$140.0K
YoY Change	-433.33%	-200.0%	-66.67%
% of Operating Profit
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$32.45M	-$24.82M	-$11.73M
YoY Change	91.45%	111.59%	-5.86%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$32.45M	-$24.82M	-$11.73M
YoY Change	91.43%	111.48%	-5.82%
Net Earnings / Revenue	-1428.84%	-598.96%	-1276.82%
Basic Earnings Per Share
Diluted Earnings Per Share	-$704.5K	-$589.8K	-$389.6K
COMMON SHARES
Basic Shares Outstanding	46.07M shares	41.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q3	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$220.8M	$258.3M	$200.6M
YoY Change	17.2%	28.76%	63.09%
Cash & Equivalents	$44.72M	$127.8M	$119.6M
Short-Term Investments	$176.1M	$130.6M	$81.00M
Other Short-Term Assets	$8.200M	$8.700M	$3.200M
YoY Change	134.29%	171.88%	6.67%
Inventory
Prepaid Expenses
Receivables	$525.0K	$2.311M	$300.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$229.5M	$269.3M	$204.2M
YoY Change	18.98%	31.88%	61.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.439M	$1.996M	$500.0K
YoY Change	121.73%	299.2%	66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$159.5M	$150.1M
YoY Change
Other Assets	$75.00K	$80.00K	$0.00
YoY Change
Total Long-Term Assets	$162.0M	$152.2M	$500.0K
YoY Change	14627.27%	30343.0%	25.0%
TOTAL ASSETS
Total Short-Term Assets	$229.5M	$269.3M	$204.2M
Total Long-Term Assets	$162.0M	$152.2M	$500.0K
Total Assets	$391.5M	$421.5M	$204.7M
YoY Change	101.81%	105.91%	61.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.92M	$9.819M	$3.100M
YoY Change	122.74%	216.74%	210.0%
Accrued Expenses	$7.782M	$10.76M	$3.600M
YoY Change	46.83%	198.83%	140.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$1.500M	$5.600M
YoY Change	-92.45%	-73.21%	0.0%
Total Short-Term Liabilities	$21.08M	$22.06M	$12.20M
YoY Change	27.73%	80.83%	50.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$100.0K	$1.500M
YoY Change	-100.0%	-93.33%	-78.87%
Other Long-Term Liabilities	$221.0K	$134.0K	$300.0K
YoY Change	-55.8%	-55.33%	0.0%
Total Long-Term Liabilities	$221.0K	$134.0K	$1.800M
YoY Change	-75.44%	-92.56%	-75.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.08M	$22.06M	$12.20M
Total Long-Term Liabilities	$221.0K	$134.0K	$1.800M
Total Liabilities	$21.30M	$22.20M	$14.00M
YoY Change	22.4%	58.54%	-9.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$301.6M	-$269.1M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$370.2M	$399.3M	$190.7M
YoY Change
Total Liabilities & Shareholders Equity	$391.5M	$421.5M	$204.7M
YoY Change	101.81%	105.91%	61.69%

Cashflow Statement

Concept	2015 Q3	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$32.45M	-$24.82M	-$11.73M
YoY Change	91.43%	111.48%	-5.82%
Depreciation, Depletion And Amortization	$180.0K	$150.0K	$50.00K
YoY Change	125.0%	200.0%	-28.57%
Cash From Operating Activities	-$24.93M	-$23.02M	-$9.630M
YoY Change	117.73%	139.04%	27.04%
INVESTING ACTIVITIES
Capital Expenditures	-$620.0K	-$820.0K	-$130.0K
YoY Change	31.91%	530.77%	550.0%
Acquisitions
YoY Change
Other Investing Activities	-$57.49M	-$65.16M	-$18.76M
YoY Change	71.77%	247.33%	-684.42%
Cash From Investing Activities	-$58.11M	-$65.98M	-$18.89M
YoY Change	71.21%	249.29%	-690.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	161.2M	110.7M
YoY Change	-107.14%	45.58%	2.7%
NET CHANGE
Cash From Operating Activities	-24.93M	-23.02M	-9.630M
Cash From Investing Activities	-58.11M	-65.98M	-18.89M
Cash From Financing Activities	-10.00K	161.2M	110.7M
Net Change In Cash	-83.05M	72.17M	82.19M
YoY Change	83.54%	-12.19%	-20.53%
FREE CASH FLOW
Cash From Operating Activities	-$24.93M	-$23.02M	-$9.630M
Capital Expenditures	-$620.0K	-$820.0K	-$130.0K
Free Cash Flow	-$24.31M	-$22.20M	-$9.500M
YoY Change	121.4%	133.68%	25.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Contracts Revenue ContractsRevenue	3833000	USD
	us-gaap	Depreciation Depreciation	95000	USD
	us-gaap	Depreciation Depreciation	264000	USD
	us-gaap	Contracts Revenue ContractsRevenue	1699000	USD
CY2015Q2	cmrx	Availablefor Sale Securities Debt Maturities Year Onethrough Two Fair Value AvailableforSaleSecuritiesDebtMaturitiesYearOnethroughTwoFairValue	150139000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46068592	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5938000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9819000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2311000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-385000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-783000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6833000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10758000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	35000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1803000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	496602000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	666586000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	644000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1415000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2801000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5203000	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	0	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	-15000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	83000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	49000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2448026	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2547571	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1211728	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1311946	shares
CY2014Q4	us-gaap	Assets Assets	291878000	USD
CY2015Q2	us-gaap	Assets Assets	421508000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	237457000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	269293000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	159087000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	280694000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	237000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2713000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	202000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	35000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	159052000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	278016000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	106114000	USD
CY2015Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	130555000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	276503000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	126364000	USD
CY2014Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	52973000	USD
CY2015Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	150139000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109976000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119601000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128462000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127776000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9625000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-686000	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45847032	shares
CY2014Q2	us-gaap	Contracts Revenue ContractsRevenue	919000	USD
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	41000	USD
CY2015Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41031770	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45847032	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41031770	shares
CY2015Q2	us-gaap	Contracts Revenue ContractsRevenue	2598000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.13
CY2014Q4	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	2.22
CY2015Q2	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	5.08
CY2014	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y6M
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P354D
CY2014	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.65
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.65
CY2014	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0044
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0028
CY2014	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.25
	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.23
	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod	P18M
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1912000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6972000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2205000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	489000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5828000	USD
CY2014Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-138000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-334000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	136000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	199000	USD
	us-gaap	Interest Paid Net InterestPaidNet	370000	USD
	us-gaap	Interest Paid Net InterestPaidNet	132000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	17242000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	22195000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	291878000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	421508000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17067000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22061000	USD
CY2014Q2	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2015Q2	us-gaap	Licenses Revenue LicensesRevenue	1545000	USD
	us-gaap	Licenses Revenue LicensesRevenue	1548000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	15000000	USD
CY2014Q4	us-gaap	Loans Payable Current LoansPayableCurrent	4296000	USD
CY2015Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1484000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110005000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161868000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81627000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120697000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18753000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41857000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-11734000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22114000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-24815000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47080000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	12515000	USD
	us-gaap	Operating Expenses OperatingExpenses	23479000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	29094000	USD
	us-gaap	Operating Expenses OperatingExpenses	52660000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11596000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21780000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-24951000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47279000	USD
CY2014Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	138000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	80000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-20000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1144000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1769000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11722000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-22134000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23671000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45311000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	175000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	134000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	147086000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	226000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	950000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	88641000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	33669000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8651000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	111845000	USD
	us-gaap	Revenues Revenues	5381000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4423000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7095000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7332000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13455000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1415000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5203000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	274636000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	399313000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30111380	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28446074	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2775000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	161880000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	229000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	461000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	7240000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	60005000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-68000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1003000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	781000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1445000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1310000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1996000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2850000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2850000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8092000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16384000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21762000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39205000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-222042000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-269122000	USD
CY2014Q2	us-gaap	Revenues Revenues	919000	USD
	us-gaap	Revenues Revenues	1699000	USD
CY2015Q2	us-gaap	Revenues Revenues	4143000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42079716	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41614494	shares

Files In Submission

Name	View Source	Status
0001117480-15-000018-index-headers.html	Edgar Link	pending
0001117480-15-000018-index.html	Edgar Link	pending
0001117480-15-000018.txt	Edgar Link	pending
0001117480-15-000018-xbrl.zip	Edgar Link	pending
a20150630cmrx10-qdocument.htm	Edgar Link	pending
a20150630cmrxex-102.htm	Edgar Link	pending
a20150630cmrxex-103.htm	Edgar Link	pending
a20150630cmrxex-311.htm	Edgar Link	pending
a20150630cmrxex-312.htm	Edgar Link	pending
a20150630cmrxex-321.htm	Edgar Link	pending
a20150630cmrxex-322.htm	Edgar Link	pending
cmrx-20150630.xml	Edgar Link	completed
cmrx-20150630.xsd	Edgar Link	pending
cmrx-20150630_cal.xml	Edgar Link	unprocessable
cmrx-20150630_def.xml	Edgar Link	unprocessable
cmrx-20150630_lab.xml	Edgar Link	unprocessable
cmrx-20150630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2015 Q3 Form 10-Q Financial Statement

#000111748015000018 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2015 Q3 Form 10-Q Financial Statement

#000111748015000018 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx